Early research (Phase 1)Study completedNCT01934738
What this trial is testing
Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)
Who this might be right for
Healthy
Pfizer 52